摘要:
Anticancer drugs consisting of sugar and protein composed primarily of xylose which are obtained from the nutrient medium and tissue-medium of Basidiomycetes such as Lentinus edodes which has been cultured in a solid medium rich is xylose such as bagasse is described.
摘要:
A control system for a stepless variable speed transmission of power splitting type for use in a vehicle in which the power from an engine is transmitted with a controllable speed and wherein part of the power is converted into hydraulic power by means of hydraulic pump motor. The system comprises an up shift valve which switches a hydraulic pressure of a clutch and brake in the transmission to change the transmission to a high speed ratio range when a speed ratio increasing hydraulic pressure in a speed ratio control actuator exceeds a given value, a down shift valve which switches the hydraulic pressure of the clutch and brake to change the transmission to a low speed ratio range when a speed ratio decreasing hydraulic pressure exceeds a given value and a directional control valve which reverse the direction of the speed ratio increasing and the speed ratio decreasing hydraulic pressure to the actuator in accordance with a pressure difference between the hydraulic pressure of the clutch and brake in the low speed ratio range and the hydraulic pressure of the clutch and brake in the high speed range.
摘要:
An automatic speed ratio control system of integration servo mechanism type for a stepless transmission of an automotive vehicle. Speed ratio is controlled by a hydraulic pump motor of variable displacement type, which in turn is controlled by an actuator having a piston and a cylinder to which hydraulic oil is supplied. The system comprises a desired value signal generator which produces a desired value signal for an engine speed corresponding to a throttle opening or an output torque of an engine or which produces a desired value signal for an engine output torque corresponding to a throttle opening or an engine speed, a detector for producing a signal indicative of an engine speed or an output torque of an engine, a control signal generator for comparing the signal from the detector against the signal from the target desired value signal generator to produce a control signal in accordance with a deviation therebetween, and a controller responsive to the control signal to drive the actuator to change a speed ratio of the stepless transmission. The system is characterized by further comprising means for producing a signal indicative of the differential or pseudo-differential of a throttle opening during the time the throttle opening increases, a signal from said means being added algebraically in opposing relationship with the signal from the desired value signal generator in the control signal generator or in opposing relationship with the signal from the control signal generator in the controller to prevent an abnormal rise in rotational speed of an engine of the vehicle during a rapid starting.
摘要:
In a hydromechanical transmission, low and high range clutches are selectively operated in response to variation of an actual speed ratio between an input shaft and an output shaft to complete low or high speed drive power train. The transmission comprises a speed ratio detecting valve for detecting lower and higher limits of a predetermined speed ratio and a clutch control valve for selectively operating the low and high range clutches when the actual speed ratio reaches in a range defined by the lower and higher limits of the predetermined speed ratio. The operation of the clutch control valve is controlled by a pressure control valve in accordance with a difference in value between a first signal responsive to a throttle opening angle and a second signal responsive to the rotation speed of the input shaft such that the low and high range clutches are selectively operated only when the difference between the first and second signals becomes a predetermined value.
摘要:
The present invention is directed to providing a safe medical adhesive, a cured body of which is hard to be degraded and decomposed and thus stable and the cured body generates less amount of acid, aldehyde, etc. due to degradation/decomposition. The medical adhesive includes a hydrophilic urethane prepolymer (UP) obtained by reacting a polyisocyanate component (A) containing a fluorine-containing non-aromatic polyisocyanate compound (A1) as an essential ingredient and a polyol component (B) containing a hydrophilic polyol (B1) as an essential ingredient, wherein a chlorine content in a chlorine-containing organic compound based on the weight of the hydrophilic urethane prepolymer (UP) is 0.005 wt % or less.
摘要:
An image forming apparatus includes a charging bias output device, a developing bias output device, a transfer bias output device, and a controller. The controller controls the transfer bias output device to supply a transfer bias from a time at which a first position of a photosensitive member arrives at a transfer position after the charging bias output device starts supplying a charging bias. An initial value of the transfer bias is controlled to be smaller than a normal set value for a predetermined time period which is a time after the transfer bias starts to be supplied and within a time corresponding to a rise time during which a surface potential of the photosensitive member reaches a predetermined potential after the charging bias starts to be output. The first position of the photosensitive member is a position at which the charging device starts charging the photosensitive member.
摘要:
A process for preparing an inclusion body-forming protein is provided. A nucleic acid fragment having a nucleotide sequence coding for a modified alkaline phosphatase signal peptide (modified APSP) where leucine at the 13th position in the amino acid sequence shown in SEQ ID NO: 1 is substituted with proline and/or alanine at the 21st position is substituted with the other amino acid, downstream of which nucleotide sequence is bound a nucleotide sequence of a gene of a protein of interest is also provided.
摘要翻译:提供了一种制备包涵体形成蛋白的方法。 具有编码改变的碱性磷酸酶信号肽(修饰的APSP)的核苷酸序列的核酸片段,其中在SEQ ID NO:1所示的氨基酸序列中的第13位的亮氨酸被第21位的脯氨酸和/或丙氨酸取代 还提供了另一个氨基酸,其下游的核苷酸序列与目的蛋白质的基因的核苷酸序列结合。
摘要:
An amplifying device includes an amplifier including a first amplifying element with a drain voltage thereof being controlled, and a second amplifying element, the amplifier amplifying a transmission signal with the first and second amplifying elements, synthesizing the transmission signals amplified by the first and second amplifying elements, and outputting the synthesized transmission signal; a distortion compensator part which performs distortion compensation on the input signal in accordance with a compensation coefficient derived from a difference between a input signal and a feedback signal generated from a portion of a signal output from the amplifier; and a controller part which controls the drain voltage of the first amplifying element in response to a result of a comparison between a power level of the input signal prior to the distortion compensation operation by the distortion compensator part and a threshold value.
摘要:
When genes encoding three kinds of proteins constituting fibrinogen, an α chain (or variant of α chain), a β chain and a γ chain (or variant of γ chain) are incorporated into an animal cell, a constitutional ratio of respective genes is such that a α chain (and/or variant of γ chain) gene is an equal amount to a 1000-fold amount relative to an α chain (and/or variant of α chain) gene and a β chain gene and, further, by using a baculovirus P35 gene, a recombinant fibrinogen highly producing cell is prepared.
摘要:
The activated Factor XI is provided as an antitussive for cough caused by the stimulation at the tracheal bifurcation such as chronic cough. A pharmaceutical composition for prevention, treatment and/or symptom amelioration of cough, comprising a polypeptide chain as an active ingredient and a pharmaceutically acceptable carrier, wherein the polypeptide chain consists of a full length amino acid sequence constituting activated Factor XI (hereinafter also referred to as “FXIa”), the amino acid sequence with one or several amino acids therein being deleted, substituted or added, or a partial sequence of either of the above amino acid sequences, or an amino acid sequence comprising as a part any of the above amino acid sequences.